{
  "id": 9006445,
  "title": "Telix Pharmaceuticals to acquire and merge with BlackRock-backed ITM for up to $2.35bn",
  "url": "https://urgent.news/2026/09/21/telix-pharmaceuticals-to-acquire-and-merge-with-blackrock-backed-itm",
  "topic": "business",
  "section": "Business",
  "published": "2026-09-21T20:49:51.000Z",
  "source": {
    "name": "PE Hub",
    "slug": "pe-hub",
    "url": "https://www.pehub.com/telix-pharmaceuticals-to-acquire-and-merge-with-blackrock-backed-itm-for-up-to-2-35bn/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Telix will pay $1.65 billion in cash upfront for 100 percent of ITM's shares, plus up to $700 million in contingency payments. The post Telix Pharmaceuticals to acquire and merge with BlackRock-backed ITM for up to $2.35bn appeared first on PE Hub .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Telix and radioisotope maker ITM merge in deal worth up to $2.35B",
        "url": "https://urgent.news/2026/09/21/telix-and-radioisotope-maker-itm-merge-in-deal-worth-up-to-2-35b",
        "published": "2026-09-21T13:52:07.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}